Frank E. O'Donnell, Jr. MD
Chairman and CEO
Frank E. O'Donnell, Jr. MD is founder and managing director of The Hopkins Capital Group. He currently serves asChairman and CEO of BioDelivery Sciences International (NASDAQ:BDSI), a Hopkins Capital portfolio company. He is Chairman and CEO of Accentia Specialty Pharmaceuticals, a holding company created to acquire assets which assist the commercial success of portfolio companies. Dr. O'Donnell is a graduate of the Johns Hopkins School of Medicine and received his residency training at the Wilmer Ophthalmological Institute. Dr. O'Donnell is a former professor and Chairman of the Department of Ophthalmology, St. Louis University School of Medicine. Dr. O'Donnell holds 34 U.S. Patents. He is the 2000 recipient of the Jules Stein Tribute Award conferred by Retinitis Pigmentosa International. He serves as a Trustee for St. Louis University and for the Health Careers Foundation.
James A. McNulty, CPA
Chief Financial Officer
Jim McNulty serves as Chief Financial Officer for Hopkins Capital Group, LLC and in that capacity he has served as CFO for several portfolio companies including publicly-traded Star Scientific (NASDAQ:STSI) and BioDelivery Sciences International (NASDAQ:BDSI).
Mr. McNulty has served as CFO/COO for entities founded by Hopkins Capital, including BioDelivery Sciences International, Inc.(NASDAQ:BDSI), Star Scientific, Inc. (NASDAQ:STSI), and American Prescription Providers, Inc.. He serves as CFO for Accentia, Inc., a vertically integrated specialty biopharmaceutical holding company. Accentia, Inc. includes its wholly-owned subsidiaries , The Analytica Group, Inc., TEAMM Pharmaceuticals, Inc. , AccentRx, Inc., and is 81% owner of Biovest International, Inc.
He practiced public accounting from 1971 through 1997, as co-founder/partner in three Tampa firms, with clients in a broad range of industries, and has extensive litigation support and expert testimony experience. His background in public and private accounting in both tax and audit brings to Accentia, Inc. familiarity with GAAP accounting principles, SEC reporting requirements, Sarbanes Oxley compliance, including financial controls and the critical role of an independent audit committee, budget preparation and analyses, debt and equity financings. He is a graduate of University of South Florida, is a CPA in the State of Florida and a Certified Valuation Analyst. He co-authored "Business Golf, the art of building relationships on the links" (2nd edition 2001) with veteran sports announcer, Pat Summerall.
Samuel S. Duffey
General Legal Counsel
Samuel S. Duffey is general legal counsel for the Hopkins Capital Group and serves as a Director of a number of entrepreneurial corporations. Mr. Duffey is an attorney and consultant providing business and marketing advice to various client companies regarding domestic and international marketing and finance. Mr. Duffey graduated from Drake University with a degree in Business Administration-Marketing and Drake University Law School with a Juri Doctor Degree with honors. He was a Staff Trial Attorney with the U.S. Securities and Exchange Commission. Mr. Duffey has practiced business law for more than 20 years assisting businesses in all aspects of growth and has assisted numerous companies in conducting intial public offerings.
Carlos Santos, Ph.D.
Pharmaceutical Development and Analysis
Carlos Santos received a Ph.D. in Bioinformatics from the University of Michigan in 2008. Since 1998, Dr. Santos has focused on pharmaceutical product development, intellectual property design, and regulatory strategy and planning activities for Hopkins Capital Group and its portfolio companies, Accentia Biopharmaceuticals (NASDAQ:ABPI) and Biodelivery Sciences International (NASDAQ:BDSI). At the University of Michigan, he developed automated natural language processing systems to integrate high-throughput genomic experimental data with known protein interaction pathways in metastatic prostate cancer progression. He also leads the development of an large-scale automated search and summarization engines for biomedical documents at the University of Michigan's National Center for Integrative Biomedical Informatics (NCIBI). From 1998 to 2001, he was a researcher developing b at Washington University's Institute for Biomedical Computing (IBC).